SB2134

Mississippi SB2134 prohibits health plans and Medicaid from restricting HIV/AIDS treatment access.

Mississippi SB2134 aims to ensure that health benefit plans, pharmacy benefit managers, Medicaid, and private review agents cannot deny coverage or impose restrictions on prior authorization for drugs prescribed for the treatment or prevention of HIV or AIDS. The bill defines "health benefit plan" and "pharmacy benefit manager" and specifies that if the FDA approves therapeutically equivalent drugs, at least one version must be covered without prior authorization or step therapy. The act takes effect from July 1, 2026.